The role of apoptosis, proliferation and amifostine in the myelodysplastic syndromes (MDS) and AML secondary to MDS.

被引：0
|
作者：
Parker, JE [1 ]
Fishlock, KL [1 ]
Pagliuca, A [1 ]
Mufti, GJ [1 ]
机构：
[1] Univ London Kings Coll, Sch Med & Dent, London, England
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1729
引用
收藏
页码：418A / 419A
页数：2
相关论文
共 50 条
  • [31] Molecular and Diagnostic Testing Patterns in Elderly Patients with Myelodysplastic Syndromes (MDS) in the Connect® MDS/AML Disease Registry
    George, Tracy I.
    Cogle, Christopher R.
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Komrokji, Rami S.
    Kurtin, Sandra E.
    Maciejewski, Jaroslaw P.
    Savona, Michael R.
    Scott, Bart L.
    Sekeres, Mikkael A.
    Steensma, David P.
    Flick, E. Dawn
    Kiselev, Pavel
    Louis, Chrystal U.
    Nifenecker, Melissa
    Swern, Arlene S.
    Foucar, Kathryn
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S315 - S315
  • [32] APOPTOSIS IN MYELODYSPLASTIC SYNDROME (MDS)
    GREENBERG, PL
    GINZTON, N
    RAJAPAKSA, R
    TONG, CR
    HAN, JH
    BLOOD, 1993, 82 (10) : A43 - A43
  • [33] The outcome of FUO during induction therapy of AML/MDS.
    Dabaja, B
    Kantarjian, H
    Pierce, S
    Keating, M
    Estey, E
    BLOOD, 1997, 90 (10) : 3761 - 3761
  • [34] CLASSIFICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS)
    CATOVSKY, D
    MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 : 3 - 3
  • [35] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES (MDS)
    TRICOT, G
    VLIETINCK, R
    HENDRICKX, B
    VERWILGHEN, RL
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) : 362 - 362
  • [36] IMMUNOTHERAPY STRATEGIES IN MYELODYSPLASTIC SYNDROMES (MDS)
    Gill, Saar
    LEUKEMIA RESEARCH, 2021, 108 : S57 - S57
  • [37] Cyclosporin A in the treatment of myelodysplastic syndromes (MDS)
    Shirin, AD
    Volkova, MA
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 416 - 416
  • [38] Iron overload in myelodysplastic syndromes (MDS)
    Norbert Gattermann
    International Journal of Hematology, 2018, 107 : 55 - 63
  • [39] BMT in children with myelodysplastic syndromes (MDS).
    Kardos, G
    Vossen, JMJJ
    Hoogerbrugge, PM
    BLOOD, 1997, 90 (10) : 373 - 373
  • [40] RISK ASSESSMENT IN MYELODYSPLASTIC SYNDROMES (MDS)
    Improta, S.
    Gagliardi, A.
    Lucania, A.
    Della Cioppa, P.
    Villa, M. R.
    Esposito, M.
    Quirino, A.
    Mastrullo, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 556 - 557
12345